One Nuclues - Key Elements of a Life Sciences SPAC

  • Thursday, 22 April 2021, 4:00 PM to 5:30 PM

The increasing interest in the Special Purpose Acquisition Company (SPAC) in Life Sciences, accelerated perhaps by the disruption and market dynamics created by Covid-19, is evident. The attraction of SPACs in principle to investors and Life Science companies is on the surface very clear. More stable, reduced risk, less burdensome and potentially more rapid route to an IPO. There may also be benefits in terms of valuation and pricing certainty. The importance on its ESG factors could be critical to success so this session will discuss the key considerations when creating and operating a SPAC such as the pros and cons, legal framework, leadership and governance, investment bank and market engagement and the IPO.

The event is free to attend and open to all.

Find out more from One Nucleus

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.